

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.57172945 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.57172945 |
| 3 | paraxial mesoderm development (GO:0048339) | 4.36055919 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.29794420 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 4.29794420 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 4.05888552 |
| 7 | chondrocyte proliferation (GO:0035988) | 3.97864936 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.86884248 |
| 9 | protein carboxylation (GO:0018214) | 3.86884248 |
| 10 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.83330559 |
| 11 | endodermal cell differentiation (GO:0035987) | 3.82239213 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 3.78389510 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 3.77076258 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.72484526 |
| 15 | regulation of fibrinolysis (GO:0051917) | 3.69931065 |
| 16 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.63904543 |
| 17 | glyoxylate metabolic process (GO:0046487) | 3.61560624 |
| 18 | bile acid biosynthetic process (GO:0006699) | 3.60373276 |
| 19 | regulation of protein activation cascade (GO:2000257) | 3.60199037 |
| 20 | positive regulation of osteoblast proliferation (GO:0033690) | 3.51545254 |
| 21 | complement activation, alternative pathway (GO:0006957) | 3.49239171 |
| 22 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.47751455 |
| 23 | regulation of complement activation (GO:0030449) | 3.47336694 |
| 24 | plasma lipoprotein particle clearance (GO:0034381) | 3.46109162 |
| 25 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.44967841 |
| 26 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.44452024 |
| 27 | lysine catabolic process (GO:0006554) | 3.34642409 |
| 28 | lysine metabolic process (GO:0006553) | 3.34642409 |
| 29 | axon extension involved in axon guidance (GO:0048846) | 3.31454593 |
| 30 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.31454593 |
| 31 | kidney mesenchyme development (GO:0072074) | 3.30767910 |
| 32 | metanephric mesenchyme development (GO:0072075) | 3.27758767 |
| 33 | cysteine metabolic process (GO:0006534) | 3.26838906 |
| 34 | kynurenine metabolic process (GO:0070189) | 3.24588998 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.21125754 |
| 36 | bone trabecula formation (GO:0060346) | 3.20359374 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 3.20304862 |
| 38 | cell adhesion mediated by integrin (GO:0033627) | 3.18369522 |
| 39 | sulfur amino acid catabolic process (GO:0000098) | 3.17560971 |
| 40 | low-density lipoprotein particle clearance (GO:0034383) | 3.14461754 |
| 41 | lymphangiogenesis (GO:0001946) | 3.13274358 |
| 42 | notochord development (GO:0030903) | 3.11787744 |
| 43 | fibrinolysis (GO:0042730) | 3.10768704 |
| 44 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.10306965 |
| 45 | endothelial cell morphogenesis (GO:0001886) | 3.09225476 |
| 46 | bile acid metabolic process (GO:0008206) | 3.07759919 |
| 47 | hippo signaling (GO:0035329) | 3.06656373 |
| 48 | cellular response to vitamin D (GO:0071305) | 3.04533949 |
| 49 | urea cycle (GO:0000050) | 3.03377129 |
| 50 | urea metabolic process (GO:0019627) | 3.03377129 |
| 51 | indole-containing compound catabolic process (GO:0042436) | 3.02448471 |
| 52 | indolalkylamine catabolic process (GO:0046218) | 3.02448471 |
| 53 | tryptophan catabolic process (GO:0006569) | 3.02448471 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 3.01490998 |
| 55 | positive regulation of fatty acid oxidation (GO:0046321) | 2.99765085 |
| 56 | negative chemotaxis (GO:0050919) | 2.99084738 |
| 57 | coenzyme catabolic process (GO:0009109) | 2.98480555 |
| 58 | homocysteine metabolic process (GO:0050667) | 2.96543589 |
| 59 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.95640491 |
| 60 | reverse cholesterol transport (GO:0043691) | 2.94355981 |
| 61 | regulation of triglyceride catabolic process (GO:0010896) | 2.93736488 |
| 62 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.93604901 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.92910733 |
| 64 | phospholipid homeostasis (GO:0055091) | 2.92416371 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 2.92336584 |
| 66 | triglyceride homeostasis (GO:0070328) | 2.89843420 |
| 67 | acylglycerol homeostasis (GO:0055090) | 2.89843420 |
| 68 | tryptophan metabolic process (GO:0006568) | 2.89566637 |
| 69 | glutamate metabolic process (GO:0006536) | 2.88939262 |
| 70 | substrate-dependent cell migration (GO:0006929) | 2.88100330 |
| 71 | tyrosine metabolic process (GO:0006570) | 2.86117519 |
| 72 | aspartate family amino acid catabolic process (GO:0009068) | 2.85444804 |
| 73 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.84251037 |
| 74 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.83811498 |
| 75 | protein-lipid complex remodeling (GO:0034368) | 2.83524042 |
| 76 | macromolecular complex remodeling (GO:0034367) | 2.83524042 |
| 77 | plasma lipoprotein particle remodeling (GO:0034369) | 2.83524042 |
| 78 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 2.82425860 |
| 79 | fatty acid beta-oxidation (GO:0006635) | 2.82408929 |
| 80 | positive regulation of lipid catabolic process (GO:0050996) | 2.80685681 |
| 81 | acetyl-CoA metabolic process (GO:0006084) | 2.76878080 |
| 82 | nitrogen cycle metabolic process (GO:0071941) | 2.76124262 |
| 83 | pericardium development (GO:0060039) | 2.75721952 |
| 84 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.75463098 |
| 85 | alpha-amino acid catabolic process (GO:1901606) | 2.73609138 |
| 86 | fatty acid transmembrane transport (GO:1902001) | 2.72858158 |
| 87 | serine family amino acid catabolic process (GO:0009071) | 2.72155092 |
| 88 | fatty acid oxidation (GO:0019395) | 2.70535432 |
| 89 | regulation of plasminogen activation (GO:0010755) | 2.70201532 |
| 90 | cellular response to vitamin (GO:0071295) | 2.69710421 |
| 91 | cholesterol efflux (GO:0033344) | 2.68624484 |
| 92 | ganglion development (GO:0061548) | 2.67604784 |
| 93 | regulation of sequestering of triglyceride (GO:0010889) | 2.66989118 |
| 94 | negative regulation of protein activation cascade (GO:2000258) | 2.66191066 |
| 95 | short-chain fatty acid metabolic process (GO:0046459) | 2.65419792 |
| 96 | lipid oxidation (GO:0034440) | 2.65399985 |
| 97 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.64565926 |
| 98 | aromatic amino acid family metabolic process (GO:0009072) | 2.63781361 |
| 99 | glomerular basement membrane development (GO:0032836) | 2.63723085 |
| 100 | protein heterotrimerization (GO:0070208) | 2.63546570 |
| 101 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.63153015 |
| 102 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.63055220 |
| 103 | cellular glucuronidation (GO:0052695) | 2.61152191 |
| 104 | ethanol oxidation (GO:0006069) | 2.60927202 |
| 105 | epoxygenase P450 pathway (GO:0019373) | 2.60892648 |
| 106 | fatty acid catabolic process (GO:0009062) | 2.60295749 |
| 107 | cellular modified amino acid catabolic process (GO:0042219) | 2.60173707 |
| 108 | artery development (GO:0060840) | 2.59179011 |
| 109 | cellular amino acid catabolic process (GO:0009063) | 2.58370063 |
| 110 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.58046716 |
| 111 | monocarboxylic acid catabolic process (GO:0072329) | 2.57245602 |
| 112 | anterior/posterior axis specification, embryo (GO:0008595) | 2.57013892 |
| 113 | negative regulation of lipase activity (GO:0060192) | 2.56287073 |
| 114 | plasma membrane repair (GO:0001778) | 2.55833070 |
| 115 | regulation of cholesterol homeostasis (GO:2000188) | 2.55777552 |
| 116 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.55031970 |
| 117 | positive regulation of astrocyte differentiation (GO:0048711) | 2.54820465 |
| 118 | cardiac myofibril assembly (GO:0055003) | 2.53638326 |
| 119 | cholesterol homeostasis (GO:0042632) | 2.52664349 |
| 120 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.52632753 |
| 121 | regulation of cholesterol esterification (GO:0010872) | 2.52601899 |
| 122 | sterol homeostasis (GO:0055092) | 2.52473165 |
| 123 | ketone body metabolic process (GO:1902224) | 2.50610606 |
| 124 | regulation of fatty acid oxidation (GO:0046320) | 2.49634817 |
| 125 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.48854601 |
| 126 | axon extension (GO:0048675) | 2.47763388 |
| 127 | regulation of establishment of planar polarity (GO:0090175) | 2.47665592 |
| 128 | glomerular visceral epithelial cell development (GO:0072015) | 2.47582588 |
| 129 | response to mercury ion (GO:0046689) | 2.47315337 |
| 130 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.46255723 |
| 131 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.45729470 |
| 132 | protein localization to endosome (GO:0036010) | 2.45167282 |
| 133 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.44899569 |
| 134 | collagen fibril organization (GO:0030199) | 2.44191639 |
| 135 | chondrocyte development (GO:0002063) | 2.43788164 |
| 136 | regulation of osteoblast proliferation (GO:0033688) | 2.43719094 |
| 137 | positive regulation of blood coagulation (GO:0030194) | 2.42457622 |
| 138 | positive regulation of hemostasis (GO:1900048) | 2.42457622 |
| 139 | 2-oxoglutarate metabolic process (GO:0006103) | 2.41843725 |
| 140 | regulation of cholesterol metabolic process (GO:0090181) | 2.41700425 |
| 141 | carboxylic acid catabolic process (GO:0046395) | 2.41484206 |
| 142 | organic acid catabolic process (GO:0016054) | 2.41484206 |
| 143 | protein hydroxylation (GO:0018126) | 2.40761844 |
| 144 | uronic acid metabolic process (GO:0006063) | 2.40216226 |
| 145 | glucuronate metabolic process (GO:0019585) | 2.40216226 |
| 146 | righting reflex (GO:0060013) | 2.39599016 |
| 147 | lipoprotein metabolic process (GO:0042157) | 2.39545456 |
| 148 | cofactor catabolic process (GO:0051187) | 2.39417149 |
| 149 | very long-chain fatty acid metabolic process (GO:0000038) | 2.38830995 |
| 150 | apoptotic cell clearance (GO:0043277) | 2.34494014 |
| 151 | collagen metabolic process (GO:0032963) | 2.33908769 |
| 152 | convergent extension (GO:0060026) | 2.32110552 |
| 153 | negative regulation of catenin import into nucleus (GO:0035414) | 2.31289580 |
| 154 | embryonic foregut morphogenesis (GO:0048617) | 2.31129873 |
| 155 | peptidyl-proline hydroxylation (GO:0019511) | 2.28916705 |
| 156 | smooth muscle tissue development (GO:0048745) | 2.28468279 |
| 157 | wound healing, spreading of epidermal cells (GO:0035313) | 2.28117909 |
| 158 | muscle cell migration (GO:0014812) | 2.27847470 |
| 159 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.27699138 |
| 160 | short-term memory (GO:0007614) | 2.26375928 |
| 161 | negative regulation of axon guidance (GO:1902668) | 2.26075112 |
| 162 | positive regulation of p38MAPK cascade (GO:1900745) | 2.26040645 |
| 163 | skin morphogenesis (GO:0043589) | 2.25968244 |
| 164 | morphogenesis of an epithelial sheet (GO:0002011) | 2.25389175 |
| 165 | negative regulation of BMP signaling pathway (GO:0030514) | 2.24811024 |
| 166 | collagen catabolic process (GO:0030574) | 2.24801453 |
| 167 | embryonic cranial skeleton morphogenesis (GO:0048701) | 2.24493247 |
| 168 | positive regulation of catenin import into nucleus (GO:0035413) | 2.23619952 |
| 169 | mitotic cytokinesis (GO:0000281) | 2.23543586 |
| 170 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.20843495 |
| 171 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.20424815 |
| 172 | non-canonical Wnt signaling pathway (GO:0035567) | 2.18637215 |
| 173 | dorsal/ventral axis specification (GO:0009950) | 2.18415526 |
| 174 | diterpenoid biosynthetic process (GO:0016102) | 2.17721918 |
| 175 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.16670931 |
| 176 | neuron projection extension (GO:1990138) | 2.15751538 |
| 177 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.15138102 |
| 178 | regulation of axon guidance (GO:1902667) | 2.14048785 |
| 179 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.14001724 |
| 180 | regulation of hippo signaling (GO:0035330) | 2.13665282 |
| 181 | axonal fasciculation (GO:0007413) | 2.13587200 |
| 182 | regulation of cardioblast differentiation (GO:0051890) | 2.13496441 |
| 183 | glomerular epithelial cell development (GO:0072310) | 2.12170367 |
| 184 | SMAD protein complex assembly (GO:0007183) | 2.11997795 |
| 185 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.11524981 |
| 186 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.10431364 |
| 187 | protein localization to cell surface (GO:0034394) | 2.09810443 |
| 188 | myoblast fusion (GO:0007520) | 2.09499946 |
| 189 | regulation of Rac protein signal transduction (GO:0035020) | 2.08901631 |
| 190 | mesodermal cell differentiation (GO:0048333) | 2.08008856 |
| 191 | hemidesmosome assembly (GO:0031581) | 2.07428838 |
| 192 | myofibril assembly (GO:0030239) | 2.07414284 |
| 193 | positive regulation of cardiac muscle tissue development (GO:0055025) | 2.06646069 |
| 194 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.06481567 |
| 195 | regulation of catenin import into nucleus (GO:0035412) | 2.05786100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.59467853 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.10278181 |
| 3 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.67166973 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.58788263 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.42568265 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.98435195 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.75813642 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.64403863 |
| 9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.62507215 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.42237786 |
| 11 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.39226789 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.29534709 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.19589112 |
| 14 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.08312918 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.02745524 |
| 16 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.94746309 |
| 17 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.92391769 |
| 18 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.81452282 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.80265411 |
| 20 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.76632379 |
| 21 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.76632379 |
| 22 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.73910644 |
| 23 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.68915163 |
| 24 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68537814 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.62875123 |
| 26 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.60664952 |
| 27 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.58744765 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.57874582 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57687958 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57666394 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55496130 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50728646 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48551863 |
| 34 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.46280107 |
| 35 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.45783410 |
| 36 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.44332941 |
| 37 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43620097 |
| 38 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.40853394 |
| 39 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.40155450 |
| 40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38309834 |
| 41 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.37915799 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37884762 |
| 43 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.37737188 |
| 44 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.37528556 |
| 45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.36499148 |
| 46 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.36377821 |
| 47 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.34723024 |
| 48 | CJUN_26792858_Chip-Seq_BT549_Human | 1.34274140 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.33283745 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.33210182 |
| 51 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.31047617 |
| 52 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.30983143 |
| 53 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.30949741 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29627963 |
| 55 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29300927 |
| 56 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.28671662 |
| 57 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28583270 |
| 58 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.26641464 |
| 59 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.26641464 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24333146 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24179075 |
| 62 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.24097052 |
| 63 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.23801714 |
| 64 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.23801714 |
| 65 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.23285103 |
| 66 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.22966651 |
| 67 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.22825002 |
| 68 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.22586755 |
| 69 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.21827674 |
| 70 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.21674042 |
| 71 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.20904583 |
| 72 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.18036740 |
| 73 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17581908 |
| 74 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17033635 |
| 75 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.16292039 |
| 76 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.15331213 |
| 77 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.14541617 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13563615 |
| 79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12958917 |
| 80 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12912495 |
| 81 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.12392330 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12310773 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11667365 |
| 84 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11207334 |
| 85 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10543785 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.10222628 |
| 87 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.10195897 |
| 88 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.10172273 |
| 89 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.09043133 |
| 90 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08041108 |
| 91 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06945647 |
| 92 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.06819362 |
| 93 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.04845718 |
| 94 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.04477600 |
| 95 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.04438133 |
| 96 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.04085328 |
| 97 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03394831 |
| 98 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03356671 |
| 99 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02828660 |
| 100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02735245 |
| 101 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.02519365 |
| 102 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01976890 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00821398 |
| 104 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00798994 |
| 105 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00331290 |
| 106 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.00303490 |
| 107 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.00076912 |
| 108 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.99848270 |
| 109 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99675783 |
| 110 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99382937 |
| 111 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98015256 |
| 112 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94437467 |
| 113 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93542782 |
| 114 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90881716 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90507212 |
| 116 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90300777 |
| 117 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89568320 |
| 118 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89125883 |
| 119 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.87492120 |
| 120 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.85731464 |
| 121 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85585133 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 0.85397466 |
| 123 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.85167137 |
| 124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85110651 |
| 125 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.85086666 |
| 126 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.85068979 |
| 127 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.84787549 |
| 128 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84619134 |
| 129 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83566339 |
| 130 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83234059 |
| 131 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.83134735 |
| 132 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.82932622 |
| 133 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.81699134 |
| 134 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.80961376 |
| 135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.80193914 |
| 136 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.79641688 |
| 137 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.79583595 |
| 138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79013479 |
| 139 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.78908695 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78774792 |
| 141 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78700271 |
| 142 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77833146 |
| 143 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77229059 |
| 144 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.76723099 |
| 145 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.74151578 |
| 146 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.74078680 |
| 147 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.73843326 |
| 148 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73309527 |
| 149 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.72450523 |
| 150 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.71274153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.68448566 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.60649764 |
| 3 | MP0005360_urolithiasis | 4.07914766 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.37165894 |
| 5 | MP0005365_abnormal_bile_salt | 3.20489949 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.78758484 |
| 7 | MP0009840_abnormal_foam_cell | 2.68909330 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.60410316 |
| 9 | MP0003252_abnormal_bile_duct | 2.57737255 |
| 10 | MP0003195_calcinosis | 2.56236400 |
| 11 | MP0004272_abnormal_basement_membrane | 2.50636653 |
| 12 | MP0010030_abnormal_orbit_morphology | 2.49392474 |
| 13 | MP0005275_abnormal_skin_tensile | 2.41809618 |
| 14 | MP0003941_abnormal_skin_development | 2.38700305 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.28396410 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.14590122 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.14036970 |
| 18 | MP0005503_abnormal_tendon_morphology | 2.11323350 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.09765789 |
| 20 | MP0005248_abnormal_Harderian_gland | 2.04966301 |
| 21 | MP0002877_abnormal_melanocyte_morpholog | 2.01142780 |
| 22 | MP0005332_abnormal_amino_acid | 2.00820898 |
| 23 | MP0005623_abnormal_meninges_morphology | 1.98473444 |
| 24 | MP0004084_abnormal_cardiac_muscle | 1.93776825 |
| 25 | MP0010368_abnormal_lymphatic_system | 1.77371795 |
| 26 | MP0003385_abnormal_body_wall | 1.77003711 |
| 27 | MP0004130_abnormal_muscle_cell | 1.72636132 |
| 28 | MP0009384_cardiac_valve_regurgitation | 1.70793204 |
| 29 | MP0003690_abnormal_glial_cell | 1.68852074 |
| 30 | MP0005670_abnormal_white_adipose | 1.67388352 |
| 31 | MP0003950_abnormal_plasma_membrane | 1.62633621 |
| 32 | MP0003279_aneurysm | 1.59033195 |
| 33 | MP0004036_abnormal_muscle_relaxation | 1.58107921 |
| 34 | MP0003937_abnormal_limbs/digits/tail_de | 1.57785269 |
| 35 | MP0000751_myopathy | 1.57074345 |
| 36 | MP0000534_abnormal_ureter_morphology | 1.57026324 |
| 37 | MP0009250_abnormal_appendicular_skeleto | 1.54530403 |
| 38 | MP0005083_abnormal_biliary_tract | 1.52755765 |
| 39 | MP0002118_abnormal_lipid_homeostasis | 1.52236466 |
| 40 | MP0001958_emphysema | 1.50219295 |
| 41 | MP0000428_abnormal_craniofacial_morphol | 1.46144073 |
| 42 | MP0003890_abnormal_embryonic-extraembry | 1.45576813 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.42667009 |
| 44 | MP0001542_abnormal_bone_strength | 1.41558109 |
| 45 | MP0006054_spinal_hemorrhage | 1.41264564 |
| 46 | MP0003942_abnormal_urinary_system | 1.41208038 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.39578209 |
| 48 | MP0006138_congestive_heart_failure | 1.36067725 |
| 49 | MP0005187_abnormal_penis_morphology | 1.34369333 |
| 50 | MP0003755_abnormal_palate_morphology | 1.30882161 |
| 51 | MP0005330_cardiomyopathy | 1.29088994 |
| 52 | MP0008775_abnormal_heart_ventricle | 1.28252261 |
| 53 | MP0002697_abnormal_eye_size | 1.28008795 |
| 54 | MP0003935_abnormal_craniofacial_develop | 1.22167123 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.20078431 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.18534612 |
| 57 | MP0004185_abnormal_adipocyte_glucose | 1.18124999 |
| 58 | MP0000920_abnormal_myelination | 1.16368415 |
| 59 | MP0004019_abnormal_vitamin_homeostasis | 1.16339732 |
| 60 | MP0002233_abnormal_nose_morphology | 1.16290636 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.14389200 |
| 62 | MP0004087_abnormal_muscle_fiber | 1.14148984 |
| 63 | MP0000432_abnormal_head_morphology | 1.14006281 |
| 64 | MP0002108_abnormal_muscle_morphology | 1.13152061 |
| 65 | MP0000762_abnormal_tongue_morphology | 1.11269646 |
| 66 | MP0000609_abnormal_liver_physiology | 1.10926893 |
| 67 | MP0005451_abnormal_body_composition | 1.10913698 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.10048670 |
| 69 | MP0003011_delayed_dark_adaptation | 1.08871098 |
| 70 | MP0000749_muscle_degeneration | 1.08098260 |
| 71 | MP0000747_muscle_weakness | 1.06490316 |
| 72 | MP0002168_other_aberrant_phenotype | 1.05829226 |
| 73 | MP0000462_abnormal_digestive_system | 1.05425888 |
| 74 | MP0000569_abnormal_digit_pigmentation | 1.05271107 |
| 75 | MP0005319_abnormal_enzyme/_coenzyme | 1.03697261 |
| 76 | MP0001666_abnormal_nutrient_absorption | 1.02300573 |
| 77 | MP0005375_adipose_tissue_phenotype | 1.01709529 |
| 78 | MP0001544_abnormal_cardiovascular_syste | 1.01055916 |
| 79 | MP0005385_cardiovascular_system_phenoty | 1.01055916 |
| 80 | MP0002896_abnormal_bone_mineralization | 1.00923158 |
| 81 | MP0001661_extended_life_span | 1.00774685 |
| 82 | MP0002972_abnormal_cardiac_muscle | 1.00393577 |
| 83 | MP0005257_abnormal_intraocular_pressure | 0.97519447 |
| 84 | MP0001293_anophthalmia | 0.97208724 |
| 85 | MP0005620_abnormal_muscle_contractility | 0.96639602 |
| 86 | MP0000537_abnormal_urethra_morphology | 0.95450347 |
| 87 | MP0005595_abnormal_vascular_smooth | 0.94763086 |
| 88 | MP0000778_abnormal_nervous_system | 0.94662931 |
| 89 | MP0000604_amyloidosis | 0.94442201 |
| 90 | MP0001286_abnormal_eye_development | 0.94270290 |
| 91 | MP0000003_abnormal_adipose_tissue | 0.93441110 |
| 92 | MP0003878_abnormal_ear_physiology | 0.93330338 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.93330338 |
| 94 | MP0010630_abnormal_cardiac_muscle | 0.92700061 |
| 95 | MP0002971_abnormal_brown_adipose | 0.91549191 |
| 96 | MP0000767_abnormal_smooth_muscle | 0.90903001 |
| 97 | MP0003091_abnormal_cell_migration | 0.89829431 |
| 98 | MP0004215_abnormal_myocardial_fiber | 0.89530030 |
| 99 | MP0002938_white_spotting | 0.88986492 |
| 100 | MP0002084_abnormal_developmental_patter | 0.87988501 |
| 101 | MP0002092_abnormal_eye_morphology | 0.87515091 |
| 102 | MP0002060_abnormal_skin_morphology | 0.87179605 |
| 103 | MP0010386_abnormal_urinary_bladder | 0.85885473 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.85521612 |
| 105 | MP0000750_abnormal_muscle_regeneration | 0.84981801 |
| 106 | MP0002269_muscular_atrophy | 0.84781332 |
| 107 | MP0004233_abnormal_muscle_weight | 0.83999459 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.83896541 |
| 109 | MP0000049_abnormal_middle_ear | 0.83882445 |
| 110 | MP0004134_abnormal_chest_morphology | 0.83511884 |
| 111 | MP0003329_amyloid_beta_deposits | 0.83154035 |
| 112 | MP0003045_fibrosis | 0.82632955 |
| 113 | MP0005193_abnormal_anterior_eye | 0.82506209 |
| 114 | MP0002128_abnormal_blood_circulation | 0.82204136 |
| 115 | MP0005023_abnormal_wound_healing | 0.81022206 |
| 116 | MP0009780_abnormal_chondrocyte_physiolo | 0.80777930 |
| 117 | MP0002090_abnormal_vision | 0.80546186 |
| 118 | MP0001915_intracranial_hemorrhage | 0.80329710 |
| 119 | MP0005408_hypopigmentation | 0.80268590 |
| 120 | MP0005508_abnormal_skeleton_morphology | 0.78495834 |
| 121 | MP0005164_abnormal_response_to | 0.78320647 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.77796025 |
| 123 | MP0003119_abnormal_digestive_system | 0.76634506 |
| 124 | MP0002102_abnormal_ear_morphology | 0.76268095 |
| 125 | MP0008004_abnormal_stomach_pH | 0.76191607 |
| 126 | MP0002116_abnormal_craniofacial_bone | 0.75982114 |
| 127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75713171 |
| 128 | MP0002109_abnormal_limb_morphology | 0.75517265 |
| 129 | MP0002184_abnormal_innervation | 0.75212243 |
| 130 | MP0003115_abnormal_respiratory_system | 0.75085028 |
| 131 | MP0005334_abnormal_fat_pad | 0.74466698 |
| 132 | MP0000733_abnormal_muscle_development | 0.73723493 |
| 133 | MP0005197_abnormal_uvea_morphology | 0.73551339 |
| 134 | MP0002925_abnormal_cardiovascular_devel | 0.73190669 |
| 135 | MP0002114_abnormal_axial_skeleton | 0.71987570 |
| 136 | MP0000230_abnormal_systemic_arterial | 0.70006279 |
| 137 | MP0003136_yellow_coat_color | 0.69887966 |
| 138 | MP0003137_abnormal_impulse_conducting | 0.69691151 |
| 139 | MP0009053_abnormal_anal_canal | 0.69465172 |
| 140 | MP0003646_muscle_fatigue | 0.68632689 |
| 141 | MP0003300_gastrointestinal_ulcer | 0.68587646 |
| 142 | MP0004858_abnormal_nervous_system | 0.68506965 |
| 143 | MP0000759_abnormal_skeletal_muscle | 0.68502015 |
| 144 | MP0002115_abnormal_skeleton_extremities | 0.68253849 |
| 145 | MP0004085_abnormal_heartbeat | 0.67977830 |
| 146 | MP0002234_abnormal_pharynx_morphology | 0.67433893 |
| 147 | MP0001756_abnormal_urination | 0.67183347 |
| 148 | MP0000163_abnormal_cartilage_morphology | 0.67142800 |
| 149 | MP0001177_atelectasis | 0.67019905 |
| 150 | MP0003868_abnormal_feces_composition | 0.66523104 |
| 151 | MP0004484_altered_response_of | 0.64991094 |
| 152 | MP0005171_absent_coat_pigmentation | 0.64252228 |
| 153 | MP0005167_abnormal_blood-brain_barrier | 0.64111785 |
| 154 | MP0003634_abnormal_glial_cell | 0.62793376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.35512144 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.61978544 |
| 3 | Xanthomatosis (HP:0000991) | 4.45909835 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.40756870 |
| 5 | Protrusio acetabuli (HP:0003179) | 3.92477817 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 3.83668964 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.71457042 |
| 8 | Complement deficiency (HP:0004431) | 3.47814339 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.32680063 |
| 10 | Aortic aneurysm (HP:0004942) | 3.26089816 |
| 11 | Overgrowth (HP:0001548) | 3.24083259 |
| 12 | Broad metatarsal (HP:0001783) | 3.21899788 |
| 13 | Hypoalphalipoproteinemia (HP:0003233) | 3.21031769 |
| 14 | Vascular tortuosity (HP:0004948) | 3.13608769 |
| 15 | Arterial tortuosity (HP:0005116) | 3.11290497 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 3.10312074 |
| 17 | Skin nodule (HP:0200036) | 3.04983606 |
| 18 | Epidermoid cyst (HP:0200040) | 2.99896818 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 2.84925866 |
| 20 | Myocardial infarction (HP:0001658) | 2.84925364 |
| 21 | Hypolipoproteinemia (HP:0010981) | 2.81153266 |
| 22 | Hypoglycemic coma (HP:0001325) | 2.79752787 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.79423170 |
| 24 | Ketosis (HP:0001946) | 2.74341380 |
| 25 | Hypobetalipoproteinemia (HP:0003563) | 2.71781527 |
| 26 | Syringomyelia (HP:0003396) | 2.68516239 |
| 27 | Spinal cord lesions (HP:0100561) | 2.68516239 |
| 28 | Hyperammonemia (HP:0001987) | 2.68113333 |
| 29 | Neonatal short-limb short stature (HP:0008921) | 2.67466251 |
| 30 | Hyperglycinemia (HP:0002154) | 2.65075213 |
| 31 | Shallow orbits (HP:0000586) | 2.64045230 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.63584124 |
| 33 | Ankle contracture (HP:0006466) | 2.61788874 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 2.58485315 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.58485315 |
| 36 | Turricephaly (HP:0000262) | 2.58244453 |
| 37 | Hyporeflexia of lower limbs (HP:0002600) | 2.55835608 |
| 38 | Vertebral compression fractures (HP:0002953) | 2.52925476 |
| 39 | Absent frontal sinuses (HP:0002688) | 2.52167504 |
| 40 | Right ventricular cardiomyopathy (HP:0011663) | 2.51630862 |
| 41 | Joint hemorrhage (HP:0005261) | 2.51170255 |
| 42 | Peritonitis (HP:0002586) | 2.50119214 |
| 43 | Muscle fiber splitting (HP:0003555) | 2.49762037 |
| 44 | Abnormality of complement system (HP:0005339) | 2.45314404 |
| 45 | Mitral stenosis (HP:0001718) | 2.44935438 |
| 46 | Increased connective tissue (HP:0009025) | 2.43438270 |
| 47 | Aortic dissection (HP:0002647) | 2.43275633 |
| 48 | Focal segmental glomerulosclerosis (HP:0000097) | 2.42515983 |
| 49 | Hypoplasia of the iris (HP:0007676) | 2.37927815 |
| 50 | Hyperglycinuria (HP:0003108) | 2.37017237 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.34776762 |
| 52 | Wormian bones (HP:0002645) | 2.33543043 |
| 53 | Abnormality of methionine metabolism (HP:0010901) | 2.32832446 |
| 54 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.32229993 |
| 55 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30869310 |
| 56 | Ketoacidosis (HP:0001993) | 2.30624247 |
| 57 | Abnormality of the intrinsic pathway (HP:0010989) | 2.29460163 |
| 58 | Cardiovascular calcification (HP:0011915) | 2.28213533 |
| 59 | Limited hip movement (HP:0008800) | 2.25159304 |
| 60 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.24958497 |
| 61 | Hypercholesterolemia (HP:0003124) | 2.24040476 |
| 62 | Axonal loss (HP:0003447) | 2.21826498 |
| 63 | Fat malabsorption (HP:0002630) | 2.20400492 |
| 64 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.13330418 |
| 65 | Sudden death (HP:0001699) | 2.11831177 |
| 66 | Follicular hyperkeratosis (HP:0007502) | 2.10133478 |
| 67 | Type 1 muscle fiber predominance (HP:0003803) | 2.09944251 |
| 68 | Mitral valve prolapse (HP:0001634) | 2.09775761 |
| 69 | Coronal craniosynostosis (HP:0004440) | 2.09399806 |
| 70 | Increased variability in muscle fiber diameter (HP:0003557) | 2.08392177 |
| 71 | Glomerulosclerosis (HP:0000096) | 2.07861479 |
| 72 | Lymphangioma (HP:0100764) | 2.07616678 |
| 73 | Hypopigmentation of the fundus (HP:0007894) | 2.06943211 |
| 74 | Exercise-induced muscle cramps (HP:0003710) | 2.06062689 |
| 75 | Biconcave vertebral bodies (HP:0004586) | 2.05703467 |
| 76 | Spondylolisthesis (HP:0003302) | 2.01804218 |
| 77 | Infantile muscular hypotonia (HP:0008947) | 2.01718608 |
| 78 | Atrophic scars (HP:0001075) | 2.01327032 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.00145839 |
| 80 | Abnormality of proline metabolism (HP:0010907) | 2.00145839 |
| 81 | Bowel diverticulosis (HP:0005222) | 1.99852423 |
| 82 | Short nail (HP:0001799) | 1.99302860 |
| 83 | Slender build (HP:0001533) | 1.98288092 |
| 84 | Blue sclerae (HP:0000592) | 1.97585286 |
| 85 | Soft skin (HP:0000977) | 1.97149382 |
| 86 | Vascular calcification (HP:0004934) | 1.96430511 |
| 87 | Genu recurvatum (HP:0002816) | 1.93894958 |
| 88 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.93345402 |
| 89 | Hepatocellular carcinoma (HP:0001402) | 1.92898909 |
| 90 | Alopecia of scalp (HP:0002293) | 1.92139544 |
| 91 | Knee flexion contracture (HP:0006380) | 1.91391119 |
| 92 | Hip contracture (HP:0003273) | 1.91318982 |
| 93 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.90686619 |
| 94 | Neurofibrillary tangles (HP:0002185) | 1.90506819 |
| 95 | Fragile skin (HP:0001030) | 1.90031906 |
| 96 | Cervical subluxation (HP:0003308) | 1.89513998 |
| 97 | Thoracolumbar scoliosis (HP:0002944) | 1.89004735 |
| 98 | Aneurysm (HP:0002617) | 1.86897647 |
| 99 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.85856660 |
| 100 | Spinal rigidity (HP:0003306) | 1.85749861 |
| 101 | Bladder diverticulum (HP:0000015) | 1.85725168 |
| 102 | Nemaline bodies (HP:0003798) | 1.85469734 |
| 103 | Esophageal varix (HP:0002040) | 1.84250580 |
| 104 | Vertebral arch anomaly (HP:0008438) | 1.83913908 |
| 105 | Abnormality of the fovea (HP:0000493) | 1.83639931 |
| 106 | Abnormality of the Achilles tendon (HP:0005109) | 1.83527821 |
| 107 | Muscle fiber inclusion bodies (HP:0100299) | 1.82942268 |
| 108 | Nephritis (HP:0000123) | 1.82888730 |
| 109 | Choroideremia (HP:0001139) | 1.82812160 |
| 110 | Pulmonic stenosis (HP:0001642) | 1.82609130 |
| 111 | Abnormal delivery (HP:0001787) | 1.82257339 |
| 112 | Limb-girdle muscle weakness (HP:0003325) | 1.81937459 |
| 113 | Hyperglycemia (HP:0003074) | 1.80918698 |
| 114 | Hepatoblastoma (HP:0002884) | 1.80213522 |
| 115 | Abnormality of the acetabulum (HP:0003170) | 1.80034158 |
| 116 | Elbow flexion contracture (HP:0002987) | 1.79460474 |
| 117 | Abnormal gallbladder morphology (HP:0012437) | 1.77433260 |
| 118 | Back pain (HP:0003418) | 1.77190359 |
| 119 | Sensorimotor neuropathy (HP:0007141) | 1.76736885 |
| 120 | Cerebral inclusion bodies (HP:0100314) | 1.75464779 |
| 121 | Cholelithiasis (HP:0001081) | 1.74421147 |
| 122 | Wrist flexion contracture (HP:0001239) | 1.74291073 |
| 123 | Osteolytic defects of the hand bones (HP:0009699) | 1.73839391 |
| 124 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.73839391 |
| 125 | Lipoatrophy (HP:0100578) | 1.73367456 |
| 126 | Round ear (HP:0100830) | 1.73071638 |
| 127 | Bell-shaped thorax (HP:0001591) | 1.72691825 |
| 128 | Abnormal cartilage morphology (HP:0002763) | 1.72069118 |
| 129 | Wide anterior fontanel (HP:0000260) | 1.71403928 |
| 130 | Hypoglycemic seizures (HP:0002173) | 1.71332941 |
| 131 | Cubitus valgus (HP:0002967) | 1.70845733 |
| 132 | Hypoventilation (HP:0002791) | 1.70247157 |
| 133 | Conjugated hyperbilirubinemia (HP:0002908) | 1.69891425 |
| 134 | Abnormality of dentin (HP:0010299) | 1.69887867 |
| 135 | Joint laxity (HP:0001388) | 1.69887405 |
| 136 | Ulnar bowing (HP:0003031) | 1.69724009 |
| 137 | Natal tooth (HP:0000695) | 1.68906018 |
| 138 | Abnormality of the ischium (HP:0003174) | 1.68320217 |
| 139 | Mitral regurgitation (HP:0001653) | 1.68080230 |
| 140 | Calcaneovalgus deformity (HP:0001848) | 1.67598493 |
| 141 | Renal duplication (HP:0000075) | 1.67492173 |
| 142 | Disproportionate tall stature (HP:0001519) | 1.67395897 |
| 143 | Abnormal pancreas size (HP:0012094) | 1.67234034 |
| 144 | Myoglobinuria (HP:0002913) | 1.66864045 |
| 145 | Hyperextensible skin (HP:0000974) | 1.66721098 |
| 146 | Hypoplastic ischia (HP:0003175) | 1.66122068 |
| 147 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.64920826 |
| 148 | Abnormality of the calf musculature (HP:0001430) | 1.63424857 |
| 149 | Aortic regurgitation (HP:0001659) | 1.61637245 |
| 150 | Abnormality of the frontal sinuses (HP:0002687) | 1.58170216 |
| 151 | Mild short stature (HP:0003502) | 1.55472762 |
| 152 | Deformed tarsal bones (HP:0008119) | 1.54135048 |
| 153 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.53955086 |
| 154 | Ectopia lentis (HP:0001083) | 1.53790650 |
| 155 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.53447811 |
| 156 | Aplasia of the phalanges of the hand (HP:0009802) | 1.53447811 |
| 157 | Aplasia involving bones of the extremities (HP:0009825) | 1.53447811 |
| 158 | Papillary thyroid carcinoma (HP:0002895) | 1.52721157 |
| 159 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.51422986 |
| 160 | Arnold-Chiari malformation (HP:0002308) | 1.50103334 |
| 161 | Scotoma (HP:0000575) | 1.49496301 |
| 162 | Flat cornea (HP:0007720) | 1.48826305 |
| 163 | Bifid tongue (HP:0010297) | 1.48722909 |
| 164 | Broad long bones (HP:0005622) | 1.48619126 |
| 165 | Preaxial foot polydactyly (HP:0001841) | 1.47456000 |
| 166 | Mesomelia (HP:0003027) | 1.46742153 |
| 167 | Long toe (HP:0010511) | 1.45864989 |
| 168 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.44984261 |
| 169 | Deviation of the hallux (HP:0010051) | 1.43831104 |
| 170 | Delayed cranial suture closure (HP:0000270) | 1.43150311 |
| 171 | Round face (HP:0000311) | 1.42825264 |
| 172 | Abnormality of the calcaneus (HP:0008364) | 1.42471167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 3.60160041 |
| 2 | TRIB3 | 3.09036664 |
| 3 | SIK1 | 2.79207191 |
| 4 | TTN | 2.74529717 |
| 5 | PDGFRA | 2.51866705 |
| 6 | STK39 | 2.42711020 |
| 7 | DDR2 | 2.35146949 |
| 8 | PKN2 | 2.33068012 |
| 9 | AKT3 | 2.17569168 |
| 10 | BCKDK | 2.04853837 |
| 11 | EPHB1 | 1.88657926 |
| 12 | MET | 1.82638065 |
| 13 | RIPK1 | 1.75270090 |
| 14 | WNK4 | 1.75261857 |
| 15 | PRPF4B | 1.72743455 |
| 16 | ERN1 | 1.70063810 |
| 17 | TIE1 | 1.56412839 |
| 18 | PNCK | 1.56198947 |
| 19 | LATS2 | 1.53940540 |
| 20 | PAK3 | 1.51922372 |
| 21 | OXSR1 | 1.48967768 |
| 22 | BMX | 1.43489428 |
| 23 | ERBB4 | 1.41704828 |
| 24 | CAMK1D | 1.41625784 |
| 25 | WNK1 | 1.39844098 |
| 26 | ERBB3 | 1.36413927 |
| 27 | FGFR4 | 1.34634599 |
| 28 | PTK6 | 1.34560297 |
| 29 | INSRR | 1.32603843 |
| 30 | FGFR2 | 1.29213589 |
| 31 | DMPK | 1.28313855 |
| 32 | EPHA3 | 1.24755601 |
| 33 | ICK | 1.22109190 |
| 34 | PBK | 1.22028026 |
| 35 | MKNK2 | 1.21540655 |
| 36 | STK3 | 1.21248388 |
| 37 | MYLK | 1.20679617 |
| 38 | MOS | 1.19843188 |
| 39 | PTK2 | 1.16745368 |
| 40 | OBSCN | 1.16211420 |
| 41 | BRSK2 | 1.14137966 |
| 42 | LIMK1 | 1.13979467 |
| 43 | FER | 1.13902256 |
| 44 | TRPM7 | 1.11346614 |
| 45 | PAK6 | 1.10777919 |
| 46 | ABL2 | 1.09544349 |
| 47 | CASK | 1.09086732 |
| 48 | PDGFRB | 1.07624905 |
| 49 | CAMK1G | 1.06086721 |
| 50 | PRKD1 | 1.05237860 |
| 51 | EPHB2 | 1.04434596 |
| 52 | MAP3K4 | 1.03290114 |
| 53 | PAK2 | 1.03216342 |
| 54 | NUAK1 | 1.02757071 |
| 55 | PIK3CA | 1.00420017 |
| 56 | STK38L | 0.97851944 |
| 57 | MST1R | 0.93750720 |
| 58 | PDPK1 | 0.92205519 |
| 59 | LMTK2 | 0.92155892 |
| 60 | PDK2 | 0.91739487 |
| 61 | NEK9 | 0.91315231 |
| 62 | PKN1 | 0.90828536 |
| 63 | PHKG1 | 0.90581240 |
| 64 | PHKG2 | 0.90581240 |
| 65 | TGFBR2 | 0.90527457 |
| 66 | PTK2B | 0.89738557 |
| 67 | STK24 | 0.89541736 |
| 68 | ROCK1 | 0.89233244 |
| 69 | MKNK1 | 0.89015261 |
| 70 | NTRK1 | 0.86924931 |
| 71 | PINK1 | 0.86595801 |
| 72 | SGK223 | 0.83377955 |
| 73 | SGK494 | 0.83377955 |
| 74 | CAMK2D | 0.82863555 |
| 75 | EPHA4 | 0.82112348 |
| 76 | BMPR1B | 0.82049931 |
| 77 | RET | 0.81731730 |
| 78 | GSK3A | 0.81326366 |
| 79 | MAP3K9 | 0.80108971 |
| 80 | PRKAA2 | 0.79414620 |
| 81 | ROCK2 | 0.78369356 |
| 82 | PRKCH | 0.77809902 |
| 83 | MTOR | 0.77294348 |
| 84 | PLK2 | 0.74971874 |
| 85 | EIF2AK3 | 0.73451048 |
| 86 | FGFR1 | 0.71776301 |
| 87 | MARK1 | 0.71508130 |
| 88 | MAP2K1 | 0.69992381 |
| 89 | SCYL2 | 0.69976198 |
| 90 | PRKCE | 0.69179848 |
| 91 | MAP3K12 | 0.68954229 |
| 92 | SGK3 | 0.68069443 |
| 93 | TGFBR1 | 0.64529197 |
| 94 | CAMK2G | 0.64214624 |
| 95 | MAP2K7 | 0.62843004 |
| 96 | MAPK7 | 0.62216083 |
| 97 | FLT3 | 0.62068438 |
| 98 | TTK | 0.61214433 |
| 99 | JAK1 | 0.60454252 |
| 100 | PDK3 | 0.60240253 |
| 101 | PDK4 | 0.60240253 |
| 102 | WEE1 | 0.59300261 |
| 103 | STK38 | 0.59288948 |
| 104 | MAP3K3 | 0.58986196 |
| 105 | MELK | 0.58825329 |
| 106 | BRD4 | 0.58757768 |
| 107 | MAP2K4 | 0.58198676 |
| 108 | MAP3K2 | 0.57464594 |
| 109 | FRK | 0.56908743 |
| 110 | MAP3K7 | 0.56737399 |
| 111 | CDC42BPA | 0.56609907 |
| 112 | NEK1 | 0.52013287 |
| 113 | PLK3 | 0.50217436 |
| 114 | CSNK1G1 | 0.50166157 |
| 115 | KSR2 | 0.49762142 |
| 116 | CSNK1A1L | 0.49645023 |
| 117 | EEF2K | 0.49595435 |
| 118 | PAK4 | 0.49484422 |
| 119 | CAMK2B | 0.49025214 |
| 120 | KSR1 | 0.48955674 |
| 121 | BCR | 0.48507217 |
| 122 | EPHA2 | 0.48001915 |
| 123 | TSSK6 | 0.45677167 |
| 124 | MAP3K1 | 0.44012159 |
| 125 | TAOK3 | 0.43715777 |
| 126 | ILK | 0.43038781 |
| 127 | PRKAA1 | 0.41979422 |
| 128 | PRKD3 | 0.41366674 |
| 129 | CAMK2A | 0.41238940 |
| 130 | WNK3 | 0.41046216 |
| 131 | SGK2 | 0.39740970 |
| 132 | PRKACG | 0.39511815 |
| 133 | TNIK | 0.39428800 |
| 134 | PRKACB | 0.38910413 |
| 135 | INSR | 0.38433100 |
| 136 | BRSK1 | 0.37703453 |
| 137 | NEK2 | 0.35303589 |
| 138 | PLK1 | 0.34074437 |
| 139 | BRAF | 0.31426019 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.37081726 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.21618914 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.83289351 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53039718 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48335165 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41900265 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.39989156 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39159406 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.32705370 |
| 10 | Hippo signaling pathway_Homo sapiens_hsa04390 | 2.19760794 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.17335837 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.14379060 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.14049987 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11360762 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.08549553 |
| 16 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.96362637 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.95699110 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.92889873 |
| 19 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.82274650 |
| 20 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.78371926 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.64797515 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63870727 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.61713450 |
| 24 | Melanoma_Homo sapiens_hsa05218 | 1.59635946 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57746684 |
| 26 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.55248712 |
| 27 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.53400136 |
| 28 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52308029 |
| 29 | Bile secretion_Homo sapiens_hsa04976 | 1.50560997 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.50004677 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49054017 |
| 32 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.48258584 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46838791 |
| 34 | Circadian rhythm_Homo sapiens_hsa04710 | 1.45881628 |
| 35 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.43497329 |
| 36 | Melanogenesis_Homo sapiens_hsa04916 | 1.41765333 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.35979290 |
| 38 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.34323515 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.33854104 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.30566033 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.29320374 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.29274523 |
| 43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.29235353 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27388703 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.26673228 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25842547 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.25794185 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22633102 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20221780 |
| 50 | Pathways in cancer_Homo sapiens_hsa05200 | 1.18938054 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.18937353 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.17419932 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16050156 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 1.14487001 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13823706 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.11922753 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11613109 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06924897 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05913173 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04833236 |
| 61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.04671507 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02572811 |
| 63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98417564 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.97287983 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.92114935 |
| 66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91088669 |
| 67 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89504009 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.89399273 |
| 69 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.88582281 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88288366 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 0.88215522 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.87191174 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86463191 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.86435930 |
| 75 | Long-term depression_Homo sapiens_hsa04730 | 0.85879927 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85563234 |
| 77 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84754103 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84616650 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.83649533 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82116380 |
| 81 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.80164178 |
| 82 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80150840 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.79003347 |
| 84 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77417996 |
| 85 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.76550309 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76354143 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76232455 |
| 88 | Prostate cancer_Homo sapiens_hsa05215 | 0.74639168 |
| 89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.73964130 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.73283924 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.73132261 |
| 92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71974811 |
| 93 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70574762 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.70269917 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.69863457 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68746040 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66392570 |
| 98 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65798709 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65737751 |
| 100 | Circadian entrainment_Homo sapiens_hsa04713 | 0.64447891 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64300283 |
| 102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63687815 |
| 103 | Renin secretion_Homo sapiens_hsa04924 | 0.63416199 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63035059 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62921792 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.62428410 |
| 107 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62015399 |
| 108 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61864114 |
| 109 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61453552 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61037796 |
| 111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.60164065 |
| 112 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.59466379 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.59392085 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58487806 |
| 115 | Cell cycle_Homo sapiens_hsa04110 | 0.58202953 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57243835 |
| 117 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55936075 |
| 118 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.55676948 |
| 119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55636421 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.55597376 |
| 121 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.55082111 |
| 122 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54244705 |
| 123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53067701 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.53044283 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52499018 |
| 126 | Morphine addiction_Homo sapiens_hsa05032 | 0.52019591 |
| 127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51130143 |
| 128 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51016569 |
| 129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50617526 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.48993565 |
| 131 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47733778 |
| 132 | GABAergic synapse_Homo sapiens_hsa04727 | 0.47451968 |
| 133 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47284521 |
| 134 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.46984209 |
| 135 | Lysosome_Homo sapiens_hsa04142 | 0.46903187 |
| 136 | Long-term potentiation_Homo sapiens_hsa04720 | 0.46680169 |
| 137 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46502184 |
| 138 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46259837 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43717706 |
| 140 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43021609 |
| 141 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42294303 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40300415 |
| 143 | Tight junction_Homo sapiens_hsa04530 | 0.32996518 |
| 144 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.32623289 |
| 145 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30659506 |
| 146 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.30270385 |
| 147 | Adherens junction_Homo sapiens_hsa04520 | 0.30220495 |
| 148 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29992998 |
| 149 | Axon guidance_Homo sapiens_hsa04360 | 0.28301509 |
| 150 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.28032200 |
| 151 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26966948 |
| 152 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25911706 |
| 153 | Malaria_Homo sapiens_hsa05144 | 0.25564151 |
| 154 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.23987935 |
| 155 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23986328 |
| 156 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23840813 |
| 157 | Phagosome_Homo sapiens_hsa04145 | 0.23678310 |
| 158 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21782231 |
| 159 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21121237 |
| 160 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.20404699 |
| 161 | Bladder cancer_Homo sapiens_hsa05219 | 0.19238824 |
| 162 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19148177 |
| 163 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.18223520 |
| 164 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.17572705 |
| 165 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.17408161 |
| 166 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.16497079 |
| 167 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16238704 |
| 168 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14421954 |

